Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Anovulation, Date of authorisation: 27/09/2013, Revision: 7, Status: Authorised

2018 Case Medical Research  
This is a summary of the European public assessment report (EPAR) for Ovaleap. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Ovaleap. For practical information about using Ovaleap, patients should read the package leaflet or contact their doctor or pharmacist.
doi:10.31525/cmr-60fb93 fatcat:vcdp3nfvkfdwpkhqs52z6idpja